FIRST CASE IN OUR POPULATION OF SPONDYLODISCITIS AND PNEUMONIA DUE TO MRSA IN A MAN WITHOUT RISK FACTORS

ABSTRACT

TYPE Case Report TOPIC Critical Care INTRODUCTION: The MDR infections are recognised in hospitals and long-term care facilities but in the last years they are increasing in the community cause a substancial health burden. CASE PRESENTATION A healthy 63 year-old man consulted with acute cervical pain and limitation of movement. No trauma and neurological compromise was found, he was treated with analgesics and discharged. Later, he was readmitted to the ER with asthenia, diffuse myalgia, dyspnea, chest pain, respiratory distress and hypoperfusion. A chest x-ray showed bilateral compromise. The initial diagnostic was viral pneumonia, acute kidney failure, and pulmonary sepsis with a SOFA score of 11 points;but SARS-CoV-2 infection was excluded. The patient required ET and vasopressors. The PCR sepsis panel detected MRSA gene mecA. He received piperacillin-tazobactam that was later adjusted to ceftaroline and linezolid due to renal compromise. The images (fig.1) showed multilobar pneumonia, bilateral pleural effusion and paravertebral inflammatory processes from C2 to C4 confirming spondylodiscitis and bacterial pneumonia. The hospital stay was 75 days, 6 weeks on antibiotics and the patient was discharged with post-ICU syndrome. DISCUSSION: The MRSA infection is a major global problem, remains a challenge to identify and to treat it. In our community, this case is probably the first in a man without comorbilities, he presented important clinical signs and developed serious complications. CONCLUSIONS: Nowadays, we should have in mind the MDR infections in patients without risk factors in order to achieve an early control and minimize the consecuence of treatment delay and possible complications. DISCLOSURE Nothing to declare. KEYWORD MRSA